Seoul YesBio registers patent for 'Cartilage culture system using biomaterials for tissue repair'

Seoul YesBio announced on February 9 that it has completed the domestic patent registration of 'Cartilage culture system using biomaterials for tissue repair', which was applied for in July last year. The patent was jointly applied for and registered by Seoul Yes Bio and Seoul Yes Hospital.

---

Seoul YesBio and Seoul Yes Hospital enter into strategic collaboration with Xeme Biopharma, USA

Collaborative Clinical Study to Develop Personalized Cancer Vaccine Treatment Seoul YesBio to expand the global market for advanced regenerative medicine

---

Seoul YesBio completes patent application for plasma freeze-drying and manufacturing method

Seoul YesBio completes patent application for plasma freeze-drying and manufacturing method

---

Seoul Yes Hospital, Seoul Yes Bio, and OfiMed sign an agreement for joint research and business cooperation on advanced regenerative medicine

In April, Seoul Yes Hospital and Seoul Yes Bio announced that they signed a joint research and development and business cooperation agreement for advanced regenerative medicine clinical research and treatment with OfiMed in a conference room at the annex of Seoul Yes Hospital in Yongin Special City.

---

Seoul YesBio signs three-way business agreement for advanced regenerative medicine and healthcare business

Seoul YesBio, an advanced regenerative medicine platform company, announced today that it has signed a three-way business agreement (MOU) with Seoul YesBio and CGBIO for joint R&D and commercialization in the field of advanced regenerative medicine and healthcare.

---

Seoul YesBio registers patent for 'Cartilage culture system using biomaterials for tissue repair'

On February 20, the company announced that it has completed the domestic patent registration of the 'Cartilage culture system using biomaterials for tissue repair' that it applied for in July last year. The patent was jointly applied for and registered by Seoul Yes Bio and Seoul Yes Hospital.

---

Seoul Yes Hospital...Advanced regenerative therapy research in full swing

Dr. Kim's research into cures for intractable diseases accelerates Selected as a center for advanced regenerative medicine at Seoul Yes Hospital by the end of 2024 Amendment to the Biotechnology Act enacted on Feb. 21 to expand patient access to treatment

---

Seoul Yes Hospital Selected to Implement Advanced Regenerative Medicine to Expand Research on Intractable Diseases

Seoul Yes Hospital, which was selected by the Ministry of Health and Welfare in December as a center for advanced regenerative medicine, announced today that it will further expand its research on advanced regenerative therapy.

---

Sigibio, Seoul Yes Hospital and others to collaborate on advanced regenerative medicine

Sigibio, Seoul Yes Hospital, and Seoul Yes Bio sign MOU for advanced regenerative medicine and healthcare business Establishing a practical cooperation system that integrates advanced regenerative medicine R&D, clinical and commercialization

---

Seoul Yes Hospital becomes the first hospital-level medical center in Yongin to be designated as an 'Advanced Regenerative Medicine Implementation Center'

Enabling advanced regenerative medicine clinical research for spine and joint disorders, intractable pain, and more

---

12